Replimune Group (NASDAQ: REPL) Stock Surges on FDA Resubmission for Melanoma Drug RP1 Replimune Group (NASDAQ: REPL)'s oncolytic immunotherapy, RP1, for advanced melanoma, received a significant boos...
Analyst Rick Wise of Stifel Nicolaus lowered Medt...
Investment firm Bernstein initiated an "Outpe...
Ciena Corporation (NYSE: CIEN) is a leading provider of optical networking solutions, crucial for supporting the increasing data demands of cloud computing and artificial intelligence. Analysts antic
Significant losses are heavily concentrated in leveraged ETFs, influenced by structural changes like reverse stock splits. The sharp price reversal in individual stocks, such as Ascent Solar Technolo
XOS (NASDAQ: XOS) surged over 234% following the announcement of a new energy storage system for data centers. Sadot Group Inc. (NASDAQ: SDOT) climbed over 105% after successfully closing its
Analyst Chuck Grom of Gordon Haskett Capital Corporation raised the price target for Macy's to $22.00, indicating positive sentiment for the department store retailer. Macy's surpassed Q1 exp
Medtronic's strong financial performance, including a decade-high top-line growth and a maintained "Buy" rating from Needham, highlights its robust market position in medical technology. The
Thor Industries (NYSE: THO) reported strong Q3 2026 revenue of $2.78 billion, surpassing analyst expectations, though it marked a 3.9% year-over-year decrease. Earnings per share (EPS) came i